Tian Shaoqi, Liu Jiangjun, Yuan Wanqing, Wang Yuanhe, Ha Chengzhi, Liu Lun, Li Qicai, Yang Xu, Sun Kang
Department of Orthopaedics, the Affiliated Hospital of Qingdao University, Qingdao, China.
PLoS One. 2017 May 4;12(5):e0176082. doi: 10.1371/journal.pone.0176082. eCollection 2017.
The purpose of this study was to explore the midterm clinical outcomes of unicompartmental knee replacement (UKR) for medial knee arthropathy through a minimally invasive approach (MIA).
From January 2006 to June 2010, 442 consecutive patients (485 knees) were included in the study. All patients underwent MIA-UKR with the mobile bearing Oxford phrase III prosthesis. The incision was made starting 1 cm medial to the medial pole of the patella and extending distally to the tibial tubercle. Radiographic evaluations include femorotibial angle (FTA) from coronal x-rays and rectified varus deformity angle, while clinical evaluations included Knee Society Score (KSS, clinical score and function score), the Western Ontario and McMaster Universities Arthritis Index (WOMAC) osteoarthritis index and visual analog scale (VAS) for pain. Patients followed-up at 1, 3, 6, 12 months after surgery and each year thereafter.
Four hundreds and two patients completed the entire follow-up, 40 patients (45 knees) were lost to follow-up. The average follow-up time was 73.0 ± 1.9 months. The mean length of the incisions was 5.0 ± 0.2 cm. The average FTA decreased from 183.6° ± 5.1° preoperatively to 174.3° ± 4.2° postoperatively, and the mean rectified varus deformity angle was 9.3° ± 1.2°. The KSS clinical score improved from 42.4 ± 2.9 to 92.9 ± 3.8, and the function score improved from 53.5 ± 3.8 to 93.5 ± 4.0. The WOMAC score improved from 47.5 ± 3.1 preoperatively to 12.3 ± 1.5 at the last evaluation. The VAS dropped from 7.8 ± 1.9 preoperatively to 1.6 ± 0.2 postoperatively. All clinical evaluations (KSS, WOMAC, VAS) were significantly different (p < 0.05) from pre and post-operative evaluations. The survival rate was 99.1% at 73 months, and the revision rate was 0.9%.
The midterm clinical outcomes of MIA-UKR are satisfactory in a Chinese patient population, which is a good surgical option for patients with medial arthropathy of the knee. However, longer-term follow-up studies should be performed in these patients.
本研究旨在通过微创方法(MIA)探索单髁膝关节置换术(UKR)治疗膝关节内侧病变的中期临床疗效。
2006年1月至2010年6月,连续纳入442例患者(485膝)。所有患者均采用活动平台牛津三代假体行MIA-UKR。切口自髌骨内侧极内侧1 cm处开始,向远端延伸至胫骨结节。影像学评估包括冠状位X线片上的股胫角(FTA)和矫正内翻畸形角,而临床评估包括膝关节协会评分(KSS,临床评分和功能评分)、西安大略和麦克马斯特大学骨关节炎指数(WOMAC)骨关节炎指数以及疼痛视觉模拟量表(VAS)。患者在术后1、3、6、12个月及此后每年进行随访。
402例患者完成了全部随访,40例患者(45膝)失访。平均随访时间为73.0±1.9个月。切口平均长度为5.0±0.2 cm。平均FTA从术前的183.6°±5.1°降至术后的174.3°±4.2°,平均矫正内翻畸形角为9.3°±1.2°。KSS临床评分从42.4±2.9提高到92.9±3.8,功能评分从53.5±3.8提高到93.5±4.0。WOMAC评分从术前的47.5±3.1降至最后一次评估时的12.3±1.5。VAS评分从术前的7.8±1.9降至术后的1.6±0.2。所有临床评估(KSS、WOMAC、VAS)术前与术后评估均有显著差异(p<0.05)。73个月时生存率为99.1%,翻修率为0.9%。
MIA-UKR在中国患者人群中的中期临床疗效令人满意,对于膝关节内侧病变患者是一种较好的手术选择。然而,应对这些患者进行长期随访研究。